Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptic vesicular amine transporter 1 (VMAT1) is a membrane-embedded protein responsible for transporting monoamine neurotransmitters into synaptic vesicles within neurons. This process is essential for the storage and subsequent regulated release of neurotransmitters such as dopamine, serotonin, norepinephrine, epinephrine, and histamine into the synaptic cleft during neurotransmission. It is encoded by the SLC18A1 gene and belongs to the solute carrier family 18 (SLC18).
Monoamine transport into synaptic vesicles
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptic Vesicular Amine Transporter 1 (VMAT1).